Tandem Diabetes (TNDM) Technical (Analysis) Reports Tandem Diabetes ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Tandem Diabetes (TNDM)
Technical Analysis Report for NASDAQ stock TNDM Tandem Diabetes. Dated: 22 May 2026 Updated Daily. Stock trades under Health Care Deals in Medical Dental Instruments in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock TNDM Tandem Diabetes then click here. or read Experts views on Tandem Diabetes or Forecast & share price targets of Tandem Diabetes
Tandem Diabetes Opened at 15.74 and Closed at: 14.97, which is -5.28% of previous session's close. It moved within a range of 14.94 and 15.92
The session was a Bearish session with an average volume of 1989700, which is -39.51% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
A Dead cross was found 6 days back on long term averages
Support for tomorrow is 14.47 and resistance for tomorrow is 15.45
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 14.63, 14.3 resistance for tomorrow's hourly charts is 15.61, 16.26
10 Day SMA for Tandem Diabetes (TNDM) is 14.37 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Tandem Diabetes (TNDM) is 16.44 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Tandem Diabetes (TNDM) is 19.22 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 20.3 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Tandem Diabetes is 18.03 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Tandem Diabetes is at 16.44 and 200 DMA is at 18.03, while 50 DMA and 100 DMA are at 19.22 and 20.3 respectively
Tandem Diabetes (TNDM) moving average of 20 SMA is at 16.44 and 20 EMA is at 16.17
| Date | Closing Price | 20 SMA | 20 EMA |
| 22 Fri May | 14.97 | 16.44 | 16.17 |
| 21 Thu May | 15.76 | 16.68 | 16.3 |
| 20 Wed May | 15.05 | 16.91 | 16.36 |
| 19 Tue May | 13.86 | 17.19 | 16.5 |
| 18 Mon May | 13.53 | 17.54 | 16.78 |
| 15 Fri May | 12.82 | 17.86 | 17.12 |
Tandem Diabetes (TNDM) moving average of 50 SMA is at 19.22 and 50 EMA is at 18.24
| Date | Closing Price | 50 SMA | 50 EMA |
| 22 Fri May | 14.97 | 19.22 | 18.24 |
| 21 Thu May | 15.76 | 19.34 | 18.37 |
| 20 Wed May | 15.05 | 19.47 | 18.48 |
| 19 Tue May | 13.86 | 19.61 | 18.62 |
| 18 Mon May | 13.53 | 19.75 | 18.81 |
| 15 Fri May | 12.82 | 19.9 | 19.03 |
Tandem Diabetes (TNDM) moving average of 100 SMA is at 20.3 and 100 EMA is at 19.12
| Date | Closing Price | 100 SMA | 100 EMA |
| 22 Fri May | 14.97 | 20.3 | 19.12 |
| 21 Thu May | 15.76 | 20.37 | 19.2 |
| 20 Wed May | 15.05 | 20.44 | 19.27 |
| 19 Tue May | 13.86 | 20.51 | 19.36 |
| 18 Mon May | 13.53 | 20.6 | 19.47 |
| 15 Fri May | 12.82 | 20.69 | 19.59 |
Tandem Diabetes (TNDM) moving average of 200 SMA is at 18.03 and 200 EMA is at 19.89
| Date | Closing Price | 200 SMA | 200 EMA |
| 22 Fri May | 14.97 | 18.03 | 19.89 |
| 21 Thu May | 15.76 | 18.02 | 19.94 |
| 20 Wed May | 15.05 | 17.99 | 19.98 |
| 19 Tue May | 13.86 | 17.99 | 20.03 |
| 18 Mon May | 13.53 | 18 | 20.09 |
| 15 Fri May | 12.82 | 18.01 | 20.16 |
Urogen Pharma has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Urogen Pharma, about 39.43% more returns!
Trupanion Inc has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Trupanion Inc, about 7.71% more returns!
Scholar Rock has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Scholar Rock, about 22.65% more returns!
Rhythm Pharmaceuticals has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 24% more returns!
Rigel Pharmaceuticals has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Rigel Pharmaceuticals, about 14.58% more returns!
Regeneron Pharmaceuticals has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Regeneron Pharmaceuticals, about 6.94% more returns!
Pulse Biosciences has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Pulse Biosciences, about 38.25% more returns!
Tandem Diabetes has performed better than Omeros Corporation in short term. Holding Tandem Diabetes could be a better choice for now!
Alkermes Plc has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Alkermes Plc, about 27.44% more returns!
Amarin Corporation has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Amarin Corporation, about 23.02% more returns!
Arrowhead Pharmaceuticals has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 26.52% more returns!
Biogen Inc has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Biogen Inc, about 25.31% more returns!
Celldex Therapeutics has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 12.13% more returns!
Dbv Technologies has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Dbv Technologies, about 7.05% more returns!
Fortress Biotech has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Fortress Biotech, about 35.38% more returns!
Fennec Pharmaceuticals has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 67.86% more returns!
Healthcare Services has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Healthcare Services, about 14.36% more returns!
Harrow Health has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Harrow Health, about 1.17% more returns!
Innoviva Inc has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Innoviva Inc, about 14.46% more returns!
Tandem Diabetes Technical analysis of indicators
Price action analysis of Tandem Diabetes (TNDM) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Tandem Diabetes stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Tandem Diabetes in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Tandem Diabetes Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Tandem Diabetes in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Tandem Diabetes is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.09 and Tandem Diabetes TNDM stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Tandem Diabetes TNDM stock. Volume based technical analysis of Tandem Diabetes TNDM stock is negative.
Tandem Diabetes Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock TNDM Tandem Diabetes These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And TNDM Experts View which covers a lot of information including buying and selling signals
TNDM future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Tandem Diabetes or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Tandem Diabetes (TNDM) Technical (Analysis) Reports Tandem Diabetes ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


